Table 4.
Percent of patients with any opioid fill occurring in monthly windows after hysterectomy.
Perioperative Fill | All Hysterectomy | Abdominal | Laparoscopic | Vaginal |
---|---|---|---|---|
Total Number of Patients | 393,096 | 133,510 | 192,017 | 67,569 |
% with Perioperative Fill | 331,322 (84.3%) | 112,408 (84.2%) | 163,724 (85.3%) | 55,190 (81.7%) |
Postoperative Period | Percent (95% CI)* | |||
Perioperative Fill | 100 (100–100) | 100 (100–100) | 100 (100–100) | 100 (100–100) |
1 – 30 Follow-up | 13.9 (13.8–14.0) | 20.0 (19.8–20.3) | 10.5 (10.4–10.7) | 11.4 (11.1–11.7) |
31 – 60 Follow-up | 3.35 (3.29–3.42) | 4.12 (4.00–4.24) | 2.92 (2.83–3.00) | 3.07 (2.92–3.22) |
61 – 90 Follow-up | 2.70 (2.64–2.76) | 2.83 (2.72–2.93) | 2.62 (2.53–2.70) | 2.68 (2.54–2.83) |
91 – 120 Follow-up | 2.66 (2.60–2.72) | 2.77 (2.66–2.87) | 2.59 (2.50–2.67) | 2.67 (2.52–2.82) |
121 – 150 Follow-up | 2.67 (2.61–2.73) | 2.78 (2.67–2.88) | 2.64 (2.56–2.73) | 2.54 (2.40–2.69) |
151 – 180 Follow-up | 2.73 (2.67–2.80) | 2.84 (2.73–2.95) | 2.69 (2.60–2.78) | 2.65 (2.50–2.81) |
181 – 210 Follow-up | 2.71 (2.64–2.77) | 2.72 (2.61–2.84) | 2.68 (2.59–2.78) | 2.73 (2.57–2.89) |
211 – 240 Follow-up | 2.70 (2.63–2.77) | 2.70 (2.58–2.81) | 2.72 (2.63–2.82) | 2.65 (2.48–2.81) |
241 – 270 Follow-up | 2.71 (2.64–2.78) | 2.77 (2.65–2.88) | 2.71 (2.61–2.80) | 2.59 (2.43–2.76) |
271 – 300 Follow-up | 2.79 (2.71–2.86) | 2.73 (2.61–2.85) | 2.82 (2.71–2.92) | 2.81 (2.64–2.99) |
301– 330 Follow-up | 2.81 (2.74–2.88) | 2.88 (2.75–3.00) | 2.76 (2.65–2.86) | 2.82 (2.64–3.00) |
331 – 365 Follow-up | 2.64 (2.56–2.71) | 2.63 (2.51–2.75) | 2.69 (2.58–2.79) | 2.51 (2.34–2.69) |
among patients with a perioperative fill